Daniel Tillett
Chief Executive Officer at RACE ONCOLOGY LIMITED
Net worth: 12 M $ as of 2024-03-30
Profile
Daniel Tillett founded Nucleics Ltd., where he worked as Chief Executive Officer.
Dr. Tillett also currently works at Race Oncology Ltd., as Chief Executive Officer from 2023.
Dr. Tillett also formerly worked at Race Oncology Ltd., as Executive Director & Chief Scientific Officer from 2020 to 2023 and Simble Solutions Ltd., as Non-Executive Director from 2022 to 2023.
Dr. Tillett received his doctorate degree from the University of New South Wales Built Environment and doctorate degree from School of Biotechnology & Biomolecular Sciences.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RACE ONCOLOGY LTD.
8.16% | 2023-08-24 | 13,480,000 ( 8.16% ) | 12 M $ | 2024-03-30 |
Daniel Tillett active positions
| Companies | Position | Start |
|---|---|---|
| RACE ONCOLOGY LIMITED | Chief Executive Officer | 2023-11-21 |
Former positions of Daniel Tillett
| Companies | Position | End |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Director/Board Member | 2023-07-02 |
| RACE ONCOLOGY LIMITED | Chief Tech/Sci/R&D Officer | 2023-03-22 |
| Nucleics Ltd. | Chief Executive Officer | - |
Training of Daniel Tillett
| University of New South Wales Built Environment | Doctorate Degree |
| School of Biotechnology & Biomolecular Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RACE ONCOLOGY LIMITED | Health Technology |
| SIMBLE SOLUTIONS LIMITED | Technology Services |
| Private companies | 1 |
|---|---|
| Nucleics Ltd. |
- Stock Market
- Insiders
- Daniel Tillett
